Understanding How Tau Protein Harms Brain Cells in Alzheimer's
Hyperphosphorylated tau and the molecular mechanisms of tauopathy
This project aims to discover how a specific protein called tau becomes toxic to brain cells in conditions like Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-11297282 on NIH RePORTER |
What this research studies
Alzheimer's disease and similar conditions are linked to an abnormal tau protein that becomes hyperphosphorylated and toxic to brain cells. We want to understand exactly how this altered tau protein damages cells and what makes it so harmful. By studying hyperphosphorylated tau, we hope to pinpoint the molecular steps involved in its toxicity and transmission. This knowledge could help us identify new targets for future medications. We are also looking for specific changes in the tau protein that drive its disease-causing effects.
Who could benefit from this research
Good fit: Patients with Alzheimer's disease or other tauopathies could potentially benefit from future therapies that emerge from this basic science research.
Not a fit: Patients seeking immediate treatment options will not directly participate in or benefit from this laboratory-based research.
Why it matters
Potential benefit: If successful, this foundational work could lead to the development of new drug targets and more effective treatments for Alzheimer's disease and other related conditions.
How similar studies have performed: While the role of tau in neurodegenerative diseases is well-known, this project explores the precise molecular mechanisms of its toxicity and transmission, which is a novel and critical area of investigation.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Kuo, Min-Hao — Michigan State University
- Study coordinator: Kuo, Min-Hao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.